Quick10K

⚲

CTS

Filings

10-Q	2021-03-31	Filed 2021-04-29
10-K	2020-12-31	Filed 2021-02-25
10-Q	2020-09-30	Filed 2020-10-29
10-Q	2020-06-30	Filed 2020-07-31
10-Q	2020-03-31	Filed 2020-04-24
10-K	2019-12-31	Filed 2020-02-20
10-Q	2019-09-30	Filed 2019-10-24
10-Q	2019-06-30	Filed 2019-07-25
10-Q	2019-03-31	Filed 2019-04-25
10-K	2018-12-31	Filed 2019-02-22
10-Q	2018-09-30	Filed 2018-10-25
10-Q	2018-06-30	Filed 2018-07-26
10-Q	2018-03-31	Filed 2018-04-26
10-K	2017-12-31	Filed 2018-02-23
10-Q	2017-09-30	Filed 2017-10-26
10-Q	2017-06-30	Filed 2017-07-27
10-Q	2017-03-31	Filed 2017-04-27
10-K	2016-12-31	Filed 2017-02-24
10-Q	2016-09-30	Filed 2016-10-28
10-Q	2016-06-30	Filed 2016-07-29
10-Q	2016-03-31	Filed 2016-05-03
10-K	2015-12-31	Filed 2016-02-24
10-Q	2015-09-27	Filed 2015-10-27
10-Q	2015-06-28	Filed 2015-07-28
10-Q	2015-03-29	Filed 2015-04-28
10-K	2014-12-31	Filed 2015-02-24
10-Q	2014-09-28	Filed 2014-10-28
10-Q	2014-06-29	Filed 2014-07-29
10-Q	2014-03-30	Filed 2014-04-29
10-K	2013-12-31	Filed 2014-03-03
10-Q	2013-09-29	Filed 2013-10-29
10-Q	2013-06-30	Filed 2013-07-25
10-Q	2013-03-31	Filed 2013-04-25
10-K	2012-12-31	Filed 2013-02-25
10-Q	2012-09-30	Filed 2012-10-24
10-Q	2012-07-01	Filed 2012-07-24
10-Q	2012-04-01	Filed 2012-04-25
10-K	2011-12-31	Filed 2012-02-24
10-Q	2011-10-02	Filed 2011-10-26
10-Q	2011-07-03	Filed 2011-07-26
10-Q	2011-04-03	Filed 2011-04-27
10-K	2010-12-31	Filed 2011-02-24
10-Q	2010-10-03	Filed 2010-10-27
10-Q	2010-07-04	Filed 2010-07-27
10-Q	2010-04-04	Filed 2010-04-28
10-K	2009-12-31	Filed 2010-02-23

Reports

8-K	2021-02-11	Other Events, Exhibits
8-K	2021-02-09	Earnings, Exhibits
8-K	2021-02-09	Regulation FD, Exhibits
8-K	2020-12-15	Exhibits
8-K	2020-10-29
8-K	2020-10-29
8-K	2020-07-31
8-K	2020-07-31
8-K	2020-07-02
8-K	2020-05-15
8-K	2020-05-01
8-K	2020-04-24
8-K	2020-04-23
8-K	2020-04-01
8-K	2020-03-05
8-K	2020-02-04
8-K	2020-02-04
8-K	2019-11-08
8-K	2019-10-25
8-K	2019-10-24
8-K	2019-08-01
8-K	2019-07-31
8-K	2019-07-25
8-K	2019-07-25
8-K	2019-05-17
8-K	2019-05-02
8-K	2019-04-30
8-K	2019-04-29
8-K	2019-04-25
8-K	2019-02-14
8-K	2019-02-08
8-K	2019-02-05
8-K	2019-02-05
8-K	2018-12-28
8-K	2018-10-25
8-K	2018-10-25
8-K	2018-07-27
8-K	2018-07-26
8-K	2018-05-22
8-K	2018-05-18
8-K	2018-05-18
8-K	2018-04-27
8-K	2018-04-26
8-K	2018-04-04
8-K	2018-02-07
8-K	2018-02-06
8-K	2018-01-16

CTS Financials

CTS Metrics, Comps, Filings

Quarterly | Annual

Valuation ($BB)

Market Cap, Enterprise Value

Balance Sheet ($BB)

Assets, Equity

Income Statement ($BB Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($BB Quarterly)

Ops, Inv, Fin


Comps ($MM TTM)	Market Cap	Gross Margin	EV/EBITDA	Ret on Assets	Assets	Liabilities	Revenue	G Profit	Net Income	EBITDA	EV
024 Pharma (EEIG)
Bioquest Corp (BQST)
11 Good Energy (ELVN)
BriaCell Therapeutics Corp. (BCTXW)
1347 Capital Corp (TFSC)
DD3 Acquisition Corp. II (DDMXW)
8i Acquisition 2 Corp. (LAX)
Acumen Pharmaceuticals, Inc. (ABOS)
Aerovate Therapeutics, Inc. (AVTE)
Ameren Illinois Co (AILNP)
Frontier Investment Corp (FICV)
Gobi Acquisition Corp. (GOBI)
HEALTH REVENUE ASSURANCE HOLDINGS, INC. (HRAA)
Ocean Biomedical, Inc. (OCEA)
SERA PROGNOSTICS, INC. (SERA)
Xiaoju Kuaizhi Inc. (DIDI)
1PM Industries (OPMZ)
1st Century Bancshares (FCTY)
COMSovereign Holding Corp. (COMSW)
ALABAMA POWER CO (APRCP)


Balance Sheet ($MM)	2011-07-03	2011-10-02	2011-12-31	2012-04-01	2012-07-01	2012-09-30	2012-12-31	2013-03-31	2013-06-30	2013-09-29	2013-12-31	2014-03-30	2014-06-29	2014-09-28	2014-12-31	2015-03-29	2015-06-28	2015-09-27	2015-12-31	2016-03-31	2016-06-30	2016-09-30	2016-12-31	2017-03-31	2017-06-30	2017-09-30	2017-12-31	2018-03-31	2018-06-30	2018-09-30	2018-12-31	2019-03-31	2019-06-30	2019-09-30
Cash	75	89	76	84	83	89	110	109	86	97	124	119	127	131	135	138	147	151	157	131	120	114	114	122	108	116	114	121	103	104	101	101	106	101
Accounts Receivable	88	90	88	90	91	81	90	94	94	97	63	68	61	63	57	67	63	59	55	65	62	62	63	63	67	65	71	70	76	79	80	82	85	81
Inventory	89	91	93	92	79	75	82	82	85	85	32	27	28	30	28	29	30	27	25	26	26	29	29	31	36	35	37	38	42	42	43	43	43	45
PP&E	79	82	326	90	91	90	334	94	91	89	267	74	74	74	71	70	70	69	70	77	77	79	82	83	85	84	88	91	94	97	99	99	100	103
Assets	495	516	481	509	490	481	561	565	529	540	480	474	480	489	457	471	489	489	484	540	520	514	518	528	538	543	540	549	543	550	548	574	581	648
Accounts Payable	77	79	80	75	66	59	68	68	71	72	47	44	44	45	43	44	46	39	40	44	42	43	40	42	43	45	49	52	52	52	52	53	51	48
Long-Term Debt						25	154				75
Liabilities	210	225	218	244	225	209	293	295	267	270	184	172	174	177	167	178	184	193	202	252	217	207	200	202	202	197	196	193	179	173	170	187	185	253
Stockholders' Equity	286	291	263	265	265	272	268	270	262	270	297	302	305	312	290	293	306	296	282	288	303	306	318	326	336	347	344	356	364	376	378	387	396	395


Income Statement ($MM)	2011-07-03	2011-10-02	2011-12-31	2012-04-01	2012-07-01	2012-09-30	2012-12-31	2013-03-31	2013-06-30	2013-09-29	2013-12-31	2014-03-30	2014-06-29	2014-09-28	2014-12-31	2015-03-29	2015-06-28	2015-09-27	2015-12-31	2016-03-31	2016-06-30	2016-09-30	2016-12-31	2017-03-31	2017-06-30	2017-09-30	2017-12-31	2018-03-31	2018-06-30	2018-09-30	2018-12-31	2019-03-31	2019-06-30	2019-09-30
Revenue	147	146	144	147	155	137	138	150	164	160	102	101	103	100	100	98	100	91	93	97	99	100	102	100	106	106	111	114	118	119	120	118	121	116
Cost of Revenue							111				72				67				63	63	64	63	66	66	70	69	78	75	76	77	77	77	79	79
Gross Profit							27				30				33				30	33	34	37	36	34	36	38	33	38	42	42	43	41	41	37
R&D	5	5	5	6	6	4	5	6	8	6	5	6	5	6	6	5	5	6	6	6	6	6	6	6	6	6	7	7	6	7		7	6	7
SG&A	18	18	17	19	20	19	22	21	23	21	7	14	16	14	16	16	15	13	14	15	16	16	15	15	16	16	25	17	20	18		18	17	18
Tax	1	2	2	1	2	2	2	1	12	4	2	4	3	4	2	3	-8	-2	13	5	8	8	3	4	4	4	6	4	4	5		3	4	4
Net Income	4	6	6	2	3	6	9	4	-11	7	-3	5	6	8	7	9	19	-5	-14	8	14	4	8	8	10	10	-14	12	7	10	18	11	12	3


Cash Flow ($MM)	2011-07-03	2011-10-02	2011-12-31	2012-04-01	2012-07-01	2012-09-30	2012-12-31	2013-03-31	2013-06-30	2013-09-29	2013-12-31	2014-03-30	2014-06-29	2014-09-28	2014-12-31	2015-03-29	2015-06-28	2015-09-27	2015-12-31	2016-03-31	2016-06-30	2016-09-30	2016-12-31	2017-03-31	2017-06-30	2017-09-30	2017-12-31	2018-03-31	2018-06-30	2018-09-30	2018-12-31	2019-03-31	2019-06-30	2019-09-30
Cash Operating		5	9	-4	16	13	17	-3	14	15	12	-6	16	5	17	0	15	9	15	0	13	18	16	10	13	24	11	20	8	15		10	15	17
Cash Investing		-4	-3	-19	-3	-3	-50	-5	-4	-2	73	-1	-3	-3	-1	-1	-3	-1	-4	-76	7	-7	-6	-4	-25	-2	-6	-7	-8	-6		-5	-4	-79
Cash Financing		13	-19	31	-15	-4	54	9	-34	-3	-58	1	-5	1	-13	4	-4	-4	-3	50	-32	-16	-11	2	-3	-13	-7	-5	-18	-8		-5	-5	58